JMJD3 Upregulates ALOX5 to Drive Malignancy and Concomitant Ferroptosis Sensitivity in Gastric Cancer

By
Noshin Noorjahan
-
0
63
Researchers demonstrated that JMJD3 is highly expressed in both gastric cancer tissues and patient-derived chemotherapy-resistant xenograft models and contributes to increased malignancy and chemoresistance.
[Cell Death & Disease]
Full Article